Tag: TOPI
Child’s Atopic Dermatitis Linked to Maternal Depression Scores
Association stronger among mothers from lower socioeconomic backgrounds managing severe child AD in early childhood
FDA Approves Zoryve for Atopic Dermatitis in Young Children
The once-daily cream can be used anywhere on the body and offers an alternative to steroids in children ages 2 to 5 years
FDA Approves Opzelura for Atopic Dermatitis in Children
It is the first topical JAK inhibitor approved in the U.S. for pediatric atopic dermatitis
Lebrikizumab Efficacious, Safe for Patients With Skin of Color, Eczema
64.4 percent of patients with postinflammatory hyperpigmented lesions at baseline experienced reduced hyperpigmentation at week 24
Novel Treatments Recommended for Management of Atopic Dermatitis in Adults
Strong recommendations presented for tapinarof cream, roflumilast cream, lebrikizumab, nemolizumab with concomitant topical therapy
FDA Approves First Cream for Treating Chronic Hand Eczema
Atopic Dermatitis May Be Linked to Increased Risk for CKD
Association between AD and increased risk for chronic kidney disease seen for men and women and in all age groups
High Dietary Inflammatory Index Tied to Increased Prevalence of Eczema
Significant sex interaction observed, with stronger associations in the female group
Prevalence, Incidence of Eczema Increase With Severity of Alopecia Areata
Those with moderate-to-severe versus mild AA had 78 percent higher risk for being diagnosed with atopic dermatitis
